Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 138,101	$ 83,295
Short-term investments	7,004	9,871
Accounts receivable, net of allowance of $24 and $27, respectively	41,716	36,594
ACO REACH performance year receivable	468,346	95,075
Current assets of discontinued operations (Note 14)	94,467	173,006
Prepaids and other current assets	38,572	36,807
Total current assets	788,206	434,648
Other assets:
Property, equipment and capitalized software, net	11,108	11,240
Intangible assets, net	68,576	71,064
Other non-current assets	27,790	27,431
Total other assets	107,474	109,735
Total assets	895,680	544,383
Current liabilities:
Medical costs payable	113,850	124,360
Accounts payable	5,451	6,298
Short-term borrowings	1,000	2,000
ACO REACH performance year obligation	382,478	0
Risk share payable to deconsolidated entity	123,981	123,981
Warrant liability	27,089	29,738
Other current liabilities	75,022	79,200
Total current liabilities	1,064,052	710,228
Total long-term borrowings	207,400	202,614
Other liabilities	17,200	17,649
Total liabilities	1,288,652	930,491
Commitments and contingencies (Note 8)
Redeemable noncontrolling interests	47,769	48,580
Redeemable Series A and B preferred stock	920,417	920,417
Shareholders’ equity (deficit):
Common stock, $0.0001 par value; $3,000,000,000 shares authorized in 2025 and 2024; $8,927,758 and $8,320,959 shares issued and outstanding in 2025 and 2024, respectively	1	1
Additional paid-in capital	3,105,109	3,099,423
Accumulated deficit	(4,454,268)	(4,442,529)
Accumulated other comprehensive loss	0	0
Treasury Stock, at cost, $31,526 shares at March 31, 2025, and December 31, 2024, respectively	(12,000)	(12,000)
Total shareholders’ equity (deficit)	(1,361,158)	(1,355,105)
Total liabilities, redeemable noncontrolling interests, redeemable preferred stock and shareholders’ equity (deficit)	895,680	544,383
Discontinued Operations
Current liabilities:
Current liabilities of discontinued operations (Note 14)	335,181	344,651
Redeemable Series A preferred stock
Current liabilities:
Redeemable Series A and B preferred stock	747,481	747,481
Redeemable Series B preferred stock
Current liabilities:
Redeemable Series A and B preferred stock	$ 172,936	$ 172,936